Key facts
- It has raised $1.3M; the latest was Seed Round ($1.1M) in Feb 2025.
- Notable investors include Techstars, Creative Destruction Lab, Investissement Quebec, CABHI, ACET — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Paperplane Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Paperplane Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Paperplane Therapeutics
Provider of virtual reality therapies intended to manage patient pain and anxiety. The company's therapies are clinically proven, interactive, and data-driven, designed for easy integration into healthcare and dental care workflows, allowing healthcare providers to deliver a non-pharmacological for pain and anxiety management that significantly elevates patient outcomes.
- Sector
- Healthcare
- HQ
- Granby, Canada
- Founded
- 2019
- Employees
- 10
- Website
- paperplanetherapeutics.com/
- Ownership
- Privately Held (backing)
Paperplane Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Paperplane Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Paperplane Therapeutics in its N-PORT filings yet. We sweep new filings monthly.